Experienced in Heterozygous Familial Hypercholesterolemia (HeFH)

Yong B. Huo

No. 8 Xishiku Street, 
Beijing, CN 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Heterozygous Familial Hypercholesterolemia (HeFH)
No. 8 Xishiku Street, 
Beijing, CN 
OverviewLocationsClinical Research

Overview

Yong Huo practices in Beijing, China. Huo is rated as an Experienced expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). Their top areas of expertise are Hypertension, Acute Coronary Syndrome, Stroke, Percutaneous Coronary Intervention (PCI), and Angioplasty.

Their clinical research consists of co-authoring 487 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Heterozygous Familial Hypercholesterolemia (HeFH).

Locations

No. 8 Xishiku Street, Beijing, China
Other Locations
Xueyuan Road, Haidian, 100083, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Comparative Efficacy of Amlodipine Folic Acid vs. Amlodipine on the Risk of First Ischemic Stroke Among Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype: A Multi-center, Randomized, Double-blind, Double-dummy, Controlled Clinical Trial
Comparative Efficacy of Amlodipine Folic Acid vs. Amlodipine on the Risk of First Ischemic Stroke Among Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype: A Multi-center, Randomized, Double-blind, Double-dummy, Controlled Clinical Trial
Enrollment Status: Recruiting
Publish Date: February 26, 2025
Intervention Type: Drug
Study Drugs: Amlodipine besylate, Folic acid
Study Phase: Phase 4
A Prospective, Multi-center, Randomized Trial To Evaluate The Safety and Efficacy of 'AVI' Stent Comparing With Firebird2® For Treating Coronary Revascularization
A Prospective, Multi-center, Randomized Trial To Evaluate The Safety and Efficacy of 'AVI' Stent Comparing With Firebird2® For Treating Coronary Revascularization
Enrollment Status: Unknown
Publish Date: November 15, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 1 Less Clinical Trial

486 Total Publications

Correction: Effect of age stratification on the association between carotid intima-media thickness and cognitive impairment in Chinese hypertensive patients: new insight from the secondary analysis of the China Stroke Primary Prevention Trial (CSPPT).
Correction: Effect of age stratification on the association between carotid intima-media thickness and cognitive impairment in Chinese hypertensive patients: new insight from the secondary analysis of the China Stroke Primary Prevention Trial (CSPPT).
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: October 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Huo's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 26 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile